There have been major advances in the armamentarium for hepatocellular carcinoma
(HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and …

One of the key strategies to improve the prognosis of HCC, beside prevention, is to diagnose
the tumor in early stages, when the patient is asymptomatic and the liver function is …

Usher syndrome (USH) is an autosomal recessive disease characterized by hearing loss,
retinitis pigmentosa (RP), and, in some cases, vestibular dysfunction. It is clinically and …

Background There is no standard treatment for unresectable hepatocellular carcinoma.
Arterial embolisation is widely used, but evidence of survival benefits is lacking. Methods We …

This study prospectively evaluates the accuracy of contrast‐enhanced ultrasound (CEUS)
and dynamic magnetic resonance imaging (MRI) for the diagnosis of nodules 20 mm or …

BACKGROUND/AIMS: This study assesses the safety, pharmacokinetics and efficacy of
transarterial chemoembolization using drug eluting beads (DEB), an embolizing device that …

Radiofrequency (RF) ablation is an alternative to percutaneous ethanol injection (PEI) for
single nonsurgical hepatocellular carcinoma (HCC) and is currently used as adjuvant …

Objective: Assessment of disease extension and activity is crucial to guide treatment in
Crohn's disease. The objective of the current cross-sectional study was to determine the …

BACKGROUND & AIMS: Transarterial chemoembolisation (TACE) improves survival of
properly selected patients with hepatocellular carcinoma (HCC). Drug eluting beads (DEB) …

Mutations in OPA1, a dynamin-related GTPase involved in mitochondrial fusion, cristae
organization and control of apoptosis, have been linked to non-syndromic optic neuropathy …